Bactrim 400/80 Deva at a Glance
Bactrim 400/80 Deva is a fixed-dose antimicrobial combination containing sulfamethoxazole and trimethoprim specifically formulated for in-vitro laboratory research applications. This pharmaceutical-grade research compound enables investigators to study antimicrobial resistance mechanisms, bacterial susceptibility profiles, and combination therapy synergistic effects in controlled laboratory environments. Available through Stroid UK Shop, this research-grade antimicrobial provides consistent results for microbiological investigations requiring standardised antifolate compound combinations.
Laboratory Applications
Research scientists investigate Bactrim 400/80 Deva in antimicrobial resistance studies, examining how bacterial strains develop resistance to sulfonamide-trimethoprim combinations. Laboratory applications include minimum inhibitory concentration (MIC) determinations, time-kill studies, and biofilm formation research. Microbiologists evaluate this compound alongside other pharmaceutical research compounds to understand bacterial adaptation mechanisms. The fixed-ratio formulation provides researchers with standardised conditions for investigating combination antimicrobial effects against various pathogenic strains, supporting comprehensive antimicrobial susceptibility testing protocols in clinical research laboratories.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Components | Sulfamethoxazole 400mg + Trimethoprim 80mg |
| Ratio | 5:1 (Sulfamethoxazole:Trimethoprim) |
| Manufacturer | Deva |
| Form | Tablet |
| Research Grade | Laboratory Standard |
| Storage | Room temperature, dry conditions |
Researchers studying antimicrobial compounds often complement their investigations with selective research modulators and bioactive peptides to understand complex biological interactions and cellular response mechanisms in comprehensive laboratory protocols.
Research Compliance
Bactrim 400/80 Deva is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical application, or therapeutic use. Researchers must conduct all investigations in accordance with institutional guidelines and appropriate laboratory safety protocols when handling antimicrobial research compounds.
